Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
Crossref DOI link: https://doi.org/10.1007/s00415-022-11053-7
Published Online: 2022-03-14
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Allman, M.
Tallantyre, E.
Robertson, N. P.
Text and Data Mining valid from 2022-03-14
Version of Record valid from 2022-03-14
Article History
Accepted: 24 February 2022
First Online: 14 March 2022